Viewing Study NCT06768905


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-01-07 @ 11:33 PM
Study NCT ID: NCT06768905
Status: RECRUITING
Last Update Posted: 2025-05-01
First Post: 2025-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of IOMAB-ACT Followed by CAR-T Cell Therapy for Patients Relapsed or Refractory (Diffuse Large B-cell Lymphoma
Sponsor: University of Texas Southwestern Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Hodgkin Lymphoma View
None Diffuse Large B Cell Lymphoma View
Keywords: